| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |